Amprion, Inc.
San Francisco, CA Doing business as Amprion Inc.
- UEI
- QBCELFPYPNJ3
- CAGE
- 6EHJ4
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 149 New Montgomery St Fl 4, San Francisco, CA 94105, USA
- Website
- ampriondx.com
- Founded
- 2007
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Protein analysis in cerebrospinal fluid samples | National Institute on Drug Abuse | $1,126,400 | |
| Protein analysis in cerebrospinal fluid samples | National Institute on Drug Abuse | $1,064,800 | |
| Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of… | National Institute of Neurological Disorders and Stroke | $4,562,401 | |
| Highly selective detection of TAU oligomers in biological fluids for the diagnosis of alzheimer's disease | National Institute on Aging | $1,461,678 | |
| Development of a biochemical diagnosis for creutzfeldt-jakob disease | National Institutes of Health | $2,468,398 |
About Amprion, Inc.
Amprion, Inc. is a for-profit corporate entity registered in SAM.gov since May 27, 2011, specializing in advanced neurological diagnostic services with a focus on protein analysis, particularly in the domain of neurodegenerative diseases. The company provides sophisticated protein analysis services centered on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing its proprietary SYNTap assay technology. The organization has demonstrated significant expertise in neurological research, specifically targeting diagnostic methodologies for understanding complex neurological conditions like Alzheimer's Disease, Parkinson's Disease, and Related Dementias.
Through its federal contract awards, Amprion, Inc. has consistently worked with the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to perform specialized protein analysis services. The company has secured multiple purchase order contracts, including a significant $2,640,000 contract awarded on August 1, 2024, for analyzing 1,200 cerebrospinal fluid samples with potential expansion to 4,800 samples. These contracts are not set-aside and were originally posted under small business sources sought notices, indicating Amprion's competitive capabilities in neurological diagnostic research. The contracts specifically involve detailed protein analysis in cerebrospinal fluid samples, demonstrating the company's technical expertise in handling complex medical research materials.
In the federal grant space, Amprion, Inc. has received awards from the National Institute of Neurological Disorders and Stroke, most notably a cooperative agreement grant (U44NS111672) awarded on May 15, 2020. This grant, valued at $1,064,800, focused on the analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids, specifically for diagnosing Parkinson's Disease. The grant supported research aimed at developing and validating advanced diagnostic techniques, with a performance period from May 15, 2020, to April 30, 2021. This grant award further underscores Amprion's commitment to innovative neurological research and diagnostic methodology development.
Quick answers
What is Amprion, Inc.'s UEI?
Amprion, Inc.'s Unique Entity ID (UEI) in SAM.gov is QBCELFPYPNJ3.
What is Amprion, Inc.'s CAGE code?
Amprion, Inc.'s CAGE code is 6EHJ4.
What is Amprion, Inc.'s primary NAICS code?
Amprion, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Amprion, Inc. located?
Amprion, Inc.'s physical address in SAM.gov is 149 New Montgomery St Fl 4, San Francisco, CA 94105, USA.
Is Amprion, Inc. registered in SAM.gov?
Yes. Amprion, Inc.'s SAM.gov registration is active through November 17, 2026.
What is Amprion, Inc.'s most recent federal award?
Amprion, Inc.'s most recent federal contract award is Protein analysis in cerebrospinal fluid samples (75N95024P00382), from National Institute on Drug Abuse, on August 1, 2024.
On GovTribe
See Amprion, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors